Lexology October 17, 2023
McDermott Will & Emery

Introduction

The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government.

Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. PBMs administer prescription drug benefits and seek discounts for insurers as standalone plans, such as Medicare Part D plans, or as entities embedded in commercial insurance products, including Medicare Advantage (MA), Medicaid Managed Care Organizations and employer-sponsored coverage. PBMs often create formularies, negotiate rebates with drug manufacturers, process claims, create pharmacy networks, review drug utilization, and manage mail-order specialty pharmacies. PBMs most often play...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Eli Lilly to invest $27B in manufacturing
AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Lilly expands US manufacturing build-out with $50B target
How AI Drug Manufacturing Is Changing the Game

Share This Article